We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$76.7B
AUM Growth
+$3.2B
Cap. Flow
-$965M
Cap. Flow %
-1.26%
Top 10 Hldgs %
9.81%
Holding
4,066
New
622
Increased
1,512
Reduced
1,263
Closed
399

Sector Composition

Rank Sector Weight
1 Technology 14.14%
2 Consumer Discretionary 12.42%
3 Healthcare 10.3%
4 Financials 9.14%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXAS
3551
DELISTED
Abraxas Petroleum Corp
AXAS
$126K ﹤0.01%
2,177
+243
+13% +$13.2K
PKD
3552
DELISTED
Parker Drilling Company
PKD
$124K ﹤0.01%
21,760
+8,708
+67% +$66.4K
TTPH
3553
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$121K ﹤0.01%
1,701
+371
+28% +$26.2K
AGTC
3554
DELISTED
Applied Genetic Technologies Corporation
AGTC
$119K ﹤0.01%
32,060
+17,758
+124% +$82.2K
JAX
3555
DELISTED
J. Alexander's Holdings, Inc.
JAX
$118K ﹤0.01%
10,542
-200
-2% -$2.38K
ASC icon
3556
Ardmore Shipping
ASC
$678M
$117K ﹤0.01%
14,213
-6,166
-30% -$49.4K
AAIC
3557
DELISTED
Arlington Asset Investment Corp.
AAIC
$117K ﹤0.01%
11,311
-33,235
-75% -$371K
RRD
3558
DELISTED
RR Donnelley & Sons Co.
RRD
$117K ﹤0.01%
20,307
-49,916
-71% -$368K
NGD
3559
DELISTED
New Gold Inc
NGD
$116K ﹤0.01%
55,659
+2,575
+5% +$5.95K
GERN icon
3560
Geron
GERN
$911M
$115K ﹤0.01%
+33,512
New +$128K
AMSC icon
3561
American Superconductor
AMSC
$1.48B
$113K ﹤0.01%
+16,084
New +$105K
TPST icon
3562
Tempest Therapeutics
TPST
$14.8M
$112K ﹤0.01%
42
IMGN
3563
DELISTED
Immunogen Inc
IMGN
$112K ﹤0.01%
11,503
-102,930
-90% -$1.09M
DSKE
3564
DELISTED
Daseke, Inc. Common Stock
DSKE
$110K ﹤0.01%
11,068
-166,331
-94% -$1.55M
AMR
3565
DELISTED
Alta Mesa Resources Inc
AMR
$109K ﹤0.01%
+15,948
New +$115K
VOXX
3566
DELISTED
VOXX International Corporation Class A
VOXX
$106K ﹤0.01%
19,714
-1,482
-7% -$7.82K
GNC
3567
CALL
DELISTED
GNC Holdings, Inc.
GNC
$106K ﹤0.01%
30,000
ICON
3568
DELISTED
Iconix Brand Group, Inc.
ICON
$105K ﹤0.01%
18,001
-51,456
-74% -$399K
QHC
3569
DELISTED
Quorum Health Corporation
QHC
$104K ﹤0.01%
20,806
-7,538
-27% -$48.3K
KNDI
3570
Kandi Technologies Group
KNDI
$65.3M
$103K ﹤0.01%
24,189
-19,605
-45% -$99K
VSI
3571
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
$99K ﹤0.01%
+14,300
New +$78K
ELDN icon
3572
Eledon Pharmaceuticals
ELDN
$276M
$98K ﹤0.01%
775
-52
-6% -$5.37K
GCAP
3573
DELISTED
Gain Capital Holdings, Inc.
GCAP
$94K ﹤0.01%
12,439
-19,796
-61% -$157K
TOUR
3574
Tuniu
TOUR
$55.4M
$92K ﹤0.01%
1,081
-10,563
-91% -$735K
DERM
3575
CALL
DELISTED
Dermira, Inc.
DERM
$92K ﹤0.01%
10,000

Similar funds

D.E. Shaw & Co's Q2 2018 Portfolio in Review

As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
  • D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
  • D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
  • D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
  • D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
  • D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.